TickerFacts.

LB Pharmaceuticals Inc (LBRX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$321.0K
Year ended 2025-12-31
2024-12-31: $91.0K2025-12-31: $321.0K$321.0K
2024-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$321.0K+252.7%2026-03-26, From 2025-01-01
2024-12-31$91.0Kn/a2026-03-26, From 2024-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
LB Pharmaceuticals Inc (LBRX)2025-12-31$321.0K+252.7%
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31$416.0K0.0%
Omeros Corp (OMER)2025-12-31$1.00M0.0%
Prothena Corp Public Ltd Co (PRTA)2025-12-31$895.0K+0.2%
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31$1.37Mn/m
Liquidia Corp (LQDA)2025-12-31$1.53M-30.5%
Rocket Pharmaceuticals, Inc. (RCKT)2025-12-31$8.90M+23.6%
ArriVent BioPharma, Inc. (AVBP)2025-12-31-$3.03Mn/a
Zentalis Pharmaceuticals, Inc. (ZNTL)2025-12-31$739.0K-42.7%

Compare LBRX, AVIR, OMER, PRTA side by side · Screen every company in Pharmaceutical Preparations ↗